Gufic Biosciences Ltd.

GUFICBIO

₹364.5

0.21% (0.75)

Market Cap

₹3,658 Cr.

P/E

44.62

About

Gufic Biosciences Limited is a public company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised stock exchan… Read more

Gufic Biosciences Limited is a public company domiciled in India and is incorporated under the… Read more

Low

278

52W Range

High

504

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
ROE

Roe has decreased vs 10 year trend
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile

Market Share

0.05 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

0.04 %

(as of May 21)

Historic

Anti-Malarial - Market Share

0.03 %

(as of Nov 21)

Historic

Blood Related - Market Share

0.01 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.02 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.04 %

(as of Aug 20)

Historic

Endocrinology - Market Share

0.04 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.04 %

(as of Nov 21)

Historic

Gynecology - Market Share

0.08 %

(as of Nov 21)

Historic

Pain - Market Share

0.03 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.01 %

(as of Nov 21)

Historic

Respiratory - Market Share

0 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

0.05 %

(as of Nov 21)

Historic

Stomatological - Market Share

0.29 %

(as of Nov 21)

Historic

Urology - Market Share

0.01 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Shapers

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

ICE Make Refrigeration Ltd.
Zim Laboratories Ltd.

FAQs on Gufic Biosciences Ltd. Business

What does Gufic Biosciences do?

Gufic Biosciences Limited, a public company from India, specializes in manufacturing and marketing active pharmaceutical ingredients and generic pharmaceuticals.

Who are the competitors of Gufic Biosciences?

Gufic Biosciences major competitors are Sequent Scientific, Orchid Pharma, Panacea Biotec, Guj. Themis Biosyn, Unichem Lab, Zota Health Care, Indoco Remedies.
Market Cap of Gufic Biosciences is ₹3,658 Crs.
While the median market cap of its peers are ₹3,177 Crs.

Is Gufic Biosciences financially stable compared to its competitors?

Gufic Biosciences seems to be less financially stable compared to its competitors.
Altman Z score of Gufic Biosciences is 5.96 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Small Cap Consistent Compounders

Small companies which consistently grow their sales , while maintaining healthy return on capital.

Run Query

Companies Doing Major Expansion

Companies in any sector undergoing sizeable expansion

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release							Jun Sep Dec
Investor Presentation		Feb Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Aug Sep	Mar Jun Dec	Mar Sep
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Gufic Biosciences Ltd.

Business Analysis Of Gufic Biosciences - Dr Vimal Agarwal

Gufic Biosciences - Business Analysis and Recommendation - Katalyst Wealth

Gufic Biosciences - Business HIghlights - Value Educator

Gufic BioSciences – Innovation driven growth - Saumik Sarangi

Gufic BioSciences Ltd - Emerging Injectables Manufacturer ? - Value Educator

View the discussion on ValuePickr

Gufic Biosciences - Niche Small Cap Pharma Company - Value Educator

KamayaKya’s stock picking philosophy, Case Study: Gufic Bioscience - Nitya Shah

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Gufic Biosciences Ltd.